Objective To construct small interfering RNA（siRNA） eukaryotic expression vector specific for human hnRNP K gene，and to observe its silencing effects on hnRNP K gene in A549 cells.Methods The expression vectors of pSUPER/hnRNP K siRNAa，pSUPER/hnRNP K siRNAc and pSUPER/siRNAn were constructed by gene recombination and then transfected into the A549 lung carcinoma cell line by using Lipofectamine2000（a and c respectively represented A and C fragments in hnRNP K coding sequence contained 19 nts，n represented nonsense fragment as control）.The mRNA and protein were harvested after 24 h and analyzed for the expression of hnRNP K by RT-PCR and Western blotting respectively.Results The siRNA vector targeted to hnRNP K successfully decreased hnRNP K mRNA and protein levels 24 h after transfection in A549 cells.Relative expressed doses of hnRNP K mRNA in lung cancer cells transfected by hnRNP K siRNAa and hnRNP K siRNAc respectively were 0.24±0.53 and 0.28±0.57 after 24 h，which were significantly lower than that in the control group（both P lt;0.01）.The gray scale values of hnRNP K protein were 0.23±0.11 and 0.28±0.09 respectively，which were also significantly lower than those in the control group（both P lt;0.05）.And pSUPER/hnRNP K siRNAa was the most effective one.Conclusion Eukaryotic expression vector of siRNA specific for hnRNP K is successfully constructed，which lays the basis for the function study of hnRNP K gene and its application in the treatment of lung carcinoma.
Citation：
TANG Fengming,LI Weimin,WANG Dongmei,HAN Juan. Construction of eukaryotic expression vector of siRNA specific for hnRNP K and characterization of its efficiency in A549 lung carcinoma cell line. Chinese Journal of Respiratory and Critical Care Medicine, 2008, 08(5): 350-353. doi:
Copy
Copyright © the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
| 1. |
Matunis MJ，Michael WM，Dreyfuss G.Characterization and primary structure of the poly（C）-binding heterogenous nuclear ribonicleoprotein complex K protein.Mol Cell Biol，1992，12：164-171.
|
| 2. |
Brendel C，Rehbein M，Kreienkamp HJ，et al.Characterization of Staufen 1 ribonucleoprotein complexes.Biochem J，2004，384：239-246.
|
| 3. |
Pino I，Pío R，Toledo G，et al.Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein（hnRNP） family in lung cancer.Lung Cancer， 2003，41：131-143.
|
| 4. |
Mandal M，Vadlamudi R，Nguyen D，et al.Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function.J Biol Chem，2001，276：9699-9704.
|
| 5. |
Schullery DS，Ostrowski J，Denisenko ON，et al.Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K protein.J Biol Chem，1999，274：15101-15109.
|
| 6. |
de Hoog CL，Foster LJ，Mann M.RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers.Cell，2004，117：649-662.
|
| 7. |
Hannon GJ.RNA interference.Nature，2002，418：244-251.
|
| 8. |
Rye PD，Stigbrand T.Interfering with cancer：a brief outline of advances in RNA interference in oncology.Tumour Biol，2004，25：329-336.
|
| 9. |
Tan FL，Yin JQ.RNAi，a new therapeutic strategy against viral infection.Cell Res，2004，14：460-466.
|
| 10. |
Pomerantz RJ.RNA interference：a potential novel therapeutic combating HIV-1 in the central nervous system.Arch Immunol Ther Exp（Warsz），2004，52：401-409.
|
| 11. |
Sui G，Soohoo C，Affar el B，et al.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.Proc Natl Acad Sci U S A，2002，99：5515-5520.
|
- 1. Matunis MJ，Michael WM，Dreyfuss G.Characterization and primary structure of the poly（C）-binding heterogenous nuclear ribonicleoprotein complex K protein.Mol Cell Biol，1992，12：164-171.
- 2. Brendel C，Rehbein M，Kreienkamp HJ，et al.Characterization of Staufen 1 ribonucleoprotein complexes.Biochem J，2004，384：239-246.
- 3. Pino I，Pío R，Toledo G，et al.Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein（hnRNP） family in lung cancer.Lung Cancer， 2003，41：131-143.
- 4. Mandal M，Vadlamudi R，Nguyen D，et al.Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function.J Biol Chem，2001，276：9699-9704.
- 5. Schullery DS，Ostrowski J，Denisenko ON，et al.Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K protein.J Biol Chem，1999，274：15101-15109.
- 6. de Hoog CL，Foster LJ，Mann M.RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers.Cell，2004，117：649-662.
- 7. Hannon GJ.RNA interference.Nature，2002，418：244-251.
- 8. Rye PD，Stigbrand T.Interfering with cancer：a brief outline of advances in RNA interference in oncology.Tumour Biol，2004，25：329-336.
- 9. Tan FL，Yin JQ.RNAi，a new therapeutic strategy against viral infection.Cell Res，2004，14：460-466.
- 10. Pomerantz RJ.RNA interference：a potential novel therapeutic combating HIV-1 in the central nervous system.Arch Immunol Ther Exp（Warsz），2004，52：401-409.
- 11. Sui G，Soohoo C，Affar el B，et al.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.Proc Natl Acad Sci U S A，2002，99：5515-5520.
